卓正医疗获赴港上市备案通知书：覆盖城市最多的私立中高端综合医疗机构

Core Viewpoint - Distinct Healthcare Holdings Limited (卓正医疗控股有限公司) has achieved profitability in 2024 after previously incurring losses, indicating a positive turnaround in its financial performance [4]. Group 1: Company Overview - Established in 2012, Distinct Healthcare focuses on the mid-to-high-end private healthcare market in China, operating 20 medical service institutions across major cities [2]. - As of March 10, 2025, the company has expanded its services to Singapore, with three general clinics [2]. - According to Frost & Sullivan, Distinct Healthcare ranks as the third-largest private mid-to-high-end healthcare service provider in China based on 2023 revenue [2]. Group 2: Patient Metrics - The total number of patients served at Distinct Healthcare's facilities in China increased from 162,393 in 2022 to 242,549 in 2024 [3]. - The total paid patient visits across all services, including online platforms, rose from 529,829 in 2022 to 905,825 in 2024 [3]. - The patient retention rate improved from 75.7% in 2022 to 80.0% in 2024, indicating enhanced customer loyalty [3]. Group 3: Financial Performance - Revenue figures for Distinct Healthcare from 2022 to 2024 were 473 million yuan, 690 million yuan, and 959 million yuan, respectively, reflecting a compound annual growth rate (CAGR) of 42.3% [3]. - The gross profit margin increased from 9.3% in 2022 to 23.6% in 2024, showcasing improved operational efficiency [3]. - The adjusted net loss decreased from 123 million yuan in 2022 to 4.3 million yuan in 2023, with a shift to an adjusted net profit of approximately 10.7 million yuan in 2024 [4]. Group 4: Investment and Valuation - Distinct Healthcare has attracted investments from notable institutions, including Tencent, which holds a 19.39% stake, making it the largest institutional investor [5][4]. - Prior to its IPO, the company's valuation was approximately 510 million USD following its last financing round in 2021 [6].